Impersonal research, traced to filings. An evidence-first read of whether Sherwin-Williams's move up the value chain is real, well-stewarded, and still underappreciated — the same for every reader, from SEC EDGAR 10-K + 8-K filings. This is not personalized advice or a recommendation to any specific person. As of 24 Jul 2026. Disclosures.
How it scores
Seven dimensions, 0–5 — the baseline everyone has (28%) plus the revealed-behaviour Analysis Bridge (72%). The method →
Baseline
Analysis Bridge
The evidence, dimension by dimension
Execution (do-side)
4/5Strong, consistent operational delivery: record sales and gross-margin expansion in a soft-volume year, met the ~2% store-growth cadence (net +80), $3.452B operating cash (14.6% of sales), $1.86B FCF after dividends, and closed/began integrating Suvinil. Marked down from 5 because GAAP EPS declined y/y (restructuring, impairment, interest) and Performance Coatings / Consumer Brands segment profit fell—execution is excellent in the core PSG engine but uneven across segments.
Say/do credibility
4/5Say/do is largely honored: the store-growth target, the 'grow despite softer-for-longer' framing, and the 47-year dividend-increase streak were all delivered, and pricing power was realized (mid-single-digit PSG price gains held gross margin up while volume fell)—the core compounder claim is credible. Tempered by a real say/do gap in 2025: reported GAAP EPS fell and OPM/ROCE compressed, with growth visible only in adjusted (Valspar-amortization-, restructuring- and impairment-excluded) figures. Management is transparent about the adjustments, so credibility is high but not maximal—guidance should be read on the adjusted basis they steer to, discounting for the recurring 'adjustments.'
Strategy — IP & partnerships
4/5Genuine structural moat, but of the brand/distribution kind rather than patent-IP. The 4,853-store company-operated network + 317 PCG branches + a controlled-brand portfolio (Sherwin-Williams, Duration, Emerald, Valspar, Purdy, Minwax) create high pro-contractor switching costs and specification lock-in—this is the 'branded ecosystem with pricing power' thesis, confirmed by the ability to push price through a soft year. Not a 5 because the company itself says patents/licenses are 'not of material importance,' so the protection is reputational/network, which is durable but not legally exclusive, and technical differentiation vs peers (PPG, Behr, Benjamin Moore) is incremental.
Governance & stewardship
4/5Solid, shareholder-aligned governance: 47 consecutive years of dividend increases, disciplined leverage policy (explicit 2.0-2.5x net-debt/EBITDA target, in covenant compliance), balanced capital allocation, and orderly board actions (annual meeting, dividend approval, officer transitions via 8-K item 5.02 on 2025-04-21 and 2025-11-03). No litigation/restatement red flags surfaced beyond the industry-standard, long-disclosed lead-pigment/lead-paint litigation. Heavy reliance on non-GAAP 'adjusted' presentation and a debt-funded, buyback-heavy return policy (equity base kept thin at $4.6B vs $10.9B debt) are watch-items rather than flags.
Margins over the cycle
Operating margin and return on capital across the last decade of SEC filings. A structural climb up the value chain holds its gains through the down-cycle; a commodity name gives them back. Structural vs cyclical →
From SEC EDGAR XBRL.
The say/do credibility ledger
What management promised, versus what the filings show they delivered — the single largest weight in the read.
| Promise | When | Status | What the filings show |
|---|---|---|---|
| Grow the Paint Stores Group store base by an approximate average of 2% per year | 10-K FY2025 Item 7 MD&A (long-standing target, restated 2026-02-19) | Delivered | Opened 83 / closed 3 = net +80 stores in 2025 to 4,853; guides 80-100 new stores for 2026. Consistent multi-year execution of the stated cadence. 10-K FY2025 Item 7 MD&A, Net Sales (Paint Stores Group) & Outlook |
| Deliver growth despite a 'softer-for-longer' demand environment via pricing and operational discipline | 10-K FY2025 Item 7 MD&A Outlook (2026-02-19; consistent with 2025 guidance framing) | Delivered | Record net sales +2.1% to $23.574B; gross margin expanded to 48.8% from 48.5% with mid-single-digit PSG price increases offsetting a low-single-digit volume decline; adjusted diluted EPS +0.9% to $11.43. Pricing power realized in a down-volume year. 10-K FY2025 Item 7 MD&A, Summary & Income Before Income Taxes; 8-K 2026-01-29 (item 2.02, Q4/FY2025 results) |
| Continue the record of returning cash and raising the dividend | 10-K FY2025 Item 7 MD&A, Shareholders' Equity | Delivered | 47th consecutive annual dividend increase; $789.8M dividends + $1.656B buybacks in 2025; board raised quarterly dividend to $0.80 (annualized $3.20) on 2026-01-26. 10-K FY2025 Item 7 MD&A, Shareholders' Equity |
| Expand up the value chain / geographically via disciplined, strategy-aligned M&A | 10-K FY2025 Item 1A & Item 7 (Suvinil close, Oct 2025) | In progress | Completed Suvinil (leading Brazilian architectural-paint brand, ~$525M sales) for ~$1.15B in Oct 2025, adding a branded LatAm franchise. Integration and expected-return realization still to be proven; 10-K explicitly flags integration risk. 10-K FY2025 Item 1A Risk Factors (acquisitions); Item 7 MD&A, Cash Flow |
| GAAP earnings growth in line with the compounder narrative | market/guidance expectation vs delivered FY2025 | Missed | GAAP diluted EPS FELL 2.7% to $10.26 (from $10.55) as $111M severance/restructuring + $17.8M trademark impairment and higher interest hit reported profit; OPM slipped to 15.8% (from 16.5%) and ROCE to 19.7% (from 22.6%). Only the adjusted metric grew. Honest gap between adjusted and GAAP delivery—weight guidance accordingly. 10-K FY2025 Item 7 MD&A, Net Income Per Share / Non-GAAP; baseline fundamentals SHW.json (OPM% / ROCE%) |
| Complete the new global HQ and R&D center investment program | prior-year plans, tracked in FY2025 10-K | Delivered | New global HQ and R&D center placed into service in 2025 (Buildings +$1.491B); only an immaterial capex remainder in 2026. Large multi-year build delivered, though it lifts 2026 interest/depreciation. 10-K FY2025 Item 7 MD&A, Property, Plant and Equipment & Real Estate Financing |
Triangulation chain
A real migration lights up all five: stated → approved → funded → permitted → protected. An announced-only one stalls early.
Articulated 'Success by Design' differentiated growth strategy: grow the branded Paint Stores base ~2%/yr, deepen the contractor/pro moat via sales reps, training, digital tools and home-builder relationships, and win share in Performance Coatings via new-account wins and favorable mix. Enterprise priorities named: talent, simplification, digitization, supply chain responsiveness, sustainability. (10-K FY2025 (filed 2026-02-19) Item 7 MD&A, Outlook)
Board-level capital deployment: quarterly dividend raised to $0.80 (Jan 26, 2026 board action, 47th consecutive annual increase); remaining buyback authorization of 29.6M shares; plan to open 80-100 new US/Canada stores in 2026; core capex targeted ~2% of net sales. (10-K FY2025 Item 7 MD&A, Shareholders' Equity & Outlook; 8-K 2025-04-21 (item 5.03/5.07 governance/AGM))
$3.452B net operating cash (14.6% of sales); funded the ~$1.15B Suvinil acquisition (Oct 2025) via delayed-draw term loans plus $797.6M capex and $2.446B returned to shareholders in-year. Net debt 2.4x EBITDA, inside the 2.0-2.5x target; $3.649B unused credit capacity. Multiple 8-K item 2.03 note issuances (2025-03-10, 08-12, 11-05, 11-17; 2026-02-09) refinance/fund the program. (10-K FY2025 Item 7 MD&A, Financial Condition/Cash Flow/Debt; 8-Ks dated 2025-08-12, 2025-11-05, 2025-11-17, 2026-02-09 (items 1.01/2.03))
Believes 'sufficient productive capacity currently exists to fulfill our needs...during 2026'; environmental compliance capex/expenses not material; capacity-expansion and maintenance projects underway in Consumer Brands and Performance Coatings. Regulatory/site permitting is not a binding constraint for a distribution-led model (stores/branches, not net-new heavy chemical plants). (10-K FY2025 Item 1 Business (Backlog and Productive Capacity); Item 7 MD&A, Environmental-Related Liabilities & PP&E)
Moat is brand + distribution/switching-cost, not patents. Deep controlled-brand portfolio across all three segments (Sherwin-Williams, Duration, Emerald, Valspar, Purdy, Minwax, Krylon, Firetex, Macropoxy, etc.); 4,853 company-operated specialty stores + 317 PCG branches lock in the pro contractor. Company states patents/licenses 'are not of material importance'—protection is trademarks, store network and specification relationships. (10-K FY2025 Item 1 Business (Trademarks and Trade Names; Patent and Licensing Income; Competition); Item 1A Risk Factors (IP))
Catalysts
- Evolving US tariff policy on imported raw materials (resins/latex/TiO2 feedstocks) could raise 2026 raw-material costs · 2026 (10-K FY2025 outlook)
Tests pricing power vs. margin; a headwind to watch but historically SHW passes cost through via price.
- One Big Beautiful Bill Act (2025) — immediate expensing of domestic capex and R&D · 2025
Raised deferred taxes and improves after-tax cash economics of US capex/R&D reinvestment.
- Suvinil acquisition closes — branded architectural-paint entry into Brazil (~$525M sales) · 2025-10 (Oct 2025)
Extends the branded-distribution model into a large LatAm market; integration is the near-term proof point.
Sources
Bridged from SEC EDGAR 10-K + 8-K filings, latest 10-K filed 19 Feb 2026. Read the 10-K on SEC EDGAR → Provenance: agent-grounded-fulltext. Financials from SEC EDGAR XBRL; price from public market data.